semaglutide eye stroke Wegovy may have highest 'eye stroke' and sight loss risk of GLP-1 agonists.⁠ ⁠ Click the link in our bio to read the full story on our website.⁠ ⁠ #medicalnews #medicine # Vision experts issue weight loss

These changes can shift numbers within weeks

Many healthcare providers and compounding pharmacies assess eligibility through metabolic history, prior weight loss attempts, and individual health risk rather than BMI alone

PlexusDx helps patients identify whether GLP-1 compounds align with their health profile

It was specifically FDA-approved for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition, such as high blood pressure or type 2 diabetes

While some people experience rebound weight gain, research shows that more than half of patients maintain their weight loss even a year after discontinuing the medication